With over 43,000 visitors and 1,500 exhibitors in one venue, CPhI & P-MEC India is South Asia's largest and most comprehensive event for the pharmaceutical industry. The fair offers the unique opportunity to experience and reach the entire pharmaceutical industry through the co-events CPhI, P-MEC, FDF, InnoPack, and Labworld. This provides an ideal platform for exchanging ideas and information with industry leaders in the areas of ingredients, machines and technology, finished dosage formulations, pharma packaging, and lab instruments & cleanroom equipment. Within this broad framework, CPhI India aims to represent every stage of the pharmaceutical supply chain and brings together major suppliers and customers of the chemical and pharmaceutical processing sector – an ideal setting for Datwyler.
Datwyler’s healthcare expertise
Being a Swiss-based company with more than 100 years of multi-industry experience, Datwyler offers state-of-the-art solutions for parenteral packaging and produces over 16 billion high-quality components for healthcare applications each year. By entering emerging markets such as India, leveraging lean production processes, and building upon an optimized supply chain, the company is prepared to master the challenges of the global healthcare industry.
The Starter Pack: From drug discovery to drug delivery
As Datwyler focuses on being a strong partner in the development and introduction of new drugs, the company developed the Starter Pack, which offers comprehensive packaging solutions to ensure drug efficacy, stability, and, ultimately, patient safety. Featuring Schott adaptiQ® vials and Datwyler’s Omni Flex stoppers and Prime Caps, the Starter Pack provides its customers with a range of compatible primary and secondary packaging components to be used in every drug development application.
The Starter Pack is designed to provide both: Superior packaging solutions and guidance for the testing and launch process. This shows that Datwyler is aware of the challenges customers are facing in their respective fields. With the Starter Pack, Datwyler provides its customers with sealing solutions for every stage of drug development. This enables them to incorporate high-quality components and commercial packaging solutions into their testing and clinical trial strategy, including diagnostic research, clinical trials, and product launch.
Datwyler in India
In keeping with the trend in the emerging Indian market, Datwyler has been operating commercial production at its plant in Pune, India, since 2012. In addition to the successful integration of First Line and Omni Flex at the Pune site last year, there was another highlight in 2018: The site became Datwyler Group's largest plant in terms of volume – with more than 4 billion products delivered by the end of 2018 and probably even more than 5 billion at year end. And it continues to grow: The next expansion is scheduled for completion by 2021. From the Pune site, customers from all over the world are supplied with state-of-the-art components – Datwyler India exports over 97% of its volume.
Visitors are warmly invited to join us at our booth at this year’s CPhI India in Delhi to experience the trends of tomorrow’s healthcare market. Our experts will be happy to meet you in Delhi for a talk about the Starter Pack, our single source solution for drug discovery through drug delivery.
When: November 26-28, 2019Where: CPhI India, India Expo Centre– Booth 14.B22, subevent P-MEC, zone 14
Healthcare